Immunogen (IMGN)

Add to Watchlists
Create an Alert
2.76 +0.00  +0.00% NASDAQ Sep 28, 09:41 Delayed 2m USD

Immunogen Cash from Financing (TTM):

101.77M for June 30, 2016
View 4,000+ financial data types
Browse...
View Full Chart

Immunogen Cash from Financing (TTM) Chart

Export Data
Save Image

Immunogen Historical Cash from Financing (TTM) Data

View and export this data going back to 1988. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
June 30, 2016 101.77M
March 31, 2016 202.11M
Dec. 31, 2015 202.04M
Sept. 30, 2015 202.88M
June 30, 2015 198.56M
March 31, 2015 2.011M
Dec. 31, 2014 3.397M
Sept. 30, 2014 5.255M
June 30, 2014 9.136M
March 31, 2014 10.36M
Dec. 31, 2013 10.23M
Sept. 30, 2013 7.348M
June 30, 2013 98.02M
March 31, 2013 99.19M
Dec. 31, 2012 99.74M
Sept. 30, 2012 100.97M
June 30, 2012 6.988M
March 31, 2012 93.79M
Dec. 31, 2011 92.32M
Sept. 30, 2011 91.30M
June 30, 2011 90.70M
March 31, 2011 79.19M
Dec. 31, 2010 79.32M
Sept. 30, 2010 80.59M
June 30, 2010 80.98M
   
March 31, 2010 41.18M
Dec. 31, 2009 41.22M
Sept. 30, 2009 39.82M
June 30, 2009 39.36M
March 31, 2009 25.90M
Dec. 31, 2008 25.30M
Sept. 30, 2008 25.88M
June 30, 2008 26.01M
March 31, 2008 1.511M
Dec. 31, 2007 2.868M
Sept. 30, 2007 2.295M
June 30, 2007 2.15M
March 31, 2007 1.703M
Dec. 31, 2006 1.141M
Sept. 30, 2006 0.935M
June 30, 2006 1.15M
March 31, 2006 1.133M
Dec. 31, 2005 0.705M
Sept. 30, 2005 0.766M
June 30, 2005 0.529M
March 31, 2005 0.858M
Dec. 31, 2004 0.5903M
Sept. 30, 2004 0.601M
June 30, 2004 0.599M
March 31, 2004 -0.018M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Cash From Financing

An item on a company's cash flow statement. Lists aggregate change in cash position resulting from financing activities. Includes the company's cash inflows and outflows from issuing cash dividends, issuing and selling stock, and adding or changing loans.
Learn More

Advertisement

IMGN Cash from Financing (TTM) Benchmarks

Companies
Array BioPharma 4.97M
Corcept Therapeutics -5.18M
Progenics Pharmaceuticals 1.34M

IMGN Cash from Financing (TTM) Range, Past 5 Years

Minimum 2.011M Mar 2015
Maximum 202.88M Sep 2015
Average 81.87M

IMGN Cash from Financing (TTM) Excel Add-In Codes

  • Metric Code: cash_financing_ttm
  • Latest data point: =YCP("IMGN", "cash_financing_ttm")
  • Last 5 data points: =YCS("IMGN", "cash_financing_ttm", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.